Sarepta Therapeutics Inc (SRPT)

Operating profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	218,081	-267,824	-536,201	-449,710	-564,163
Revenue	US$ in thousands	1,901,980	1,243,340	933,013	701,887	540,099
Operating profit margin		11.47%	-21.54%	-57.47%	-64.07%	-104.46%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $218,081K ÷ $1,901,980K
= 11.47%

Sarepta Therapeutics Inc's operating profit margin has shown a sharp improvement over the years based on the provided data. In December 31, 2020, the operating profit margin was deeply negative at -104.46%, indicating significant operating losses. However, the company managed to narrow its losses in the following years, with the margin improving to -64.07% in December 31, 2021, and further to -57.47% in December 31, 2022.

The trend continued to show positive signs as of December 31, 2023, with the operating profit margin significantly improving to -21.54%. Finally, by December 31, 2024, Sarepta Therapeutics Inc was able to achieve a positive operating profit margin of 11.47%, demonstrating a turnaround from the previous years of losses.

This improvement in the operating profit margin suggests that the company has been able to manage its operating expenses more efficiently, increase revenue, or a combination of both, leading to a healthier bottom line. It indicates positive progress in the company's operational efficiency and financial performance over the years covered in the data.